HERTFORDSHIRE, England and PITTSBURGH, March 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the Company will present at the Raymond James 37th Annual Institutional Investors Conference on Wednesday, March 9, 2016, in Orlando. The presentation is scheduled to begin at 10:25 a.m. ET.
Interested parties can access a live webcast of the presentation via the investor relations section of Mylan’s Web site at www.mylan.com/investors.
About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which nearly 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world’s largest producers of active pharmaceutical ingredients. Every member of our nearly 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-raymond-james-37th-annual-institutional-investors-conference-300231014.html
SOURCE Mylan N.V.
